Showing results (1-10 of 7) with videos related to
Sort By:
Pageof 1
Critical Reviews in Clinical Laboratory Sciences|April 18, 2018
Novel heart failure biomarkers: why do we fail to exploit their potential?Arnold Piek, Weijie Du, Rudolf A de Boer, et al.European Journal of Heart Failure|August 19, 2020
A combined bioinformatics, experimental and clinical approach to identify novel cardiac-specific heart failure biomarkers: is Dickkopf-3 (DKK3) a possible candidate?Arnold Piek, Navin Suthahar, Adriaan A Voors, et al.Scientific Reports|April 22, 2021
The emerging plasma biomarker Dickkopf-3 (DKK3) and its association with renal and cardiovascular disease in the general populationArnold Piek, Leonie Smit, Navin Suthahar, et al.Journal of Cardiac Failure|May 26, 2016
HE4 Serum Levels Are Associated with Heart Failure Severity in Patients With Chronic Heart FailureArnold Piek, Wouter C Meijers, Nicolas F Schroten, et al.Scientific Reports|December 12, 2019
Pharmacological myeloperoxidase (MPO) inhibition in an obese/hypertensive mouse model attenuates obesity and liver damage, but not cardiac remodelingArnold Piek, Debby P Y Koonen, Elisabeth-Maria Schouten, et al.Theranostics|August 22, 2018
Plasma levels of heart failure biomarkers are primarily a reflection of extracardiac productionWeijie Du, Arnold Piek, E Marloes Schouten, et al.American Journal of Physiology. Heart and Circulatory Physiology|April 13, 2019
A novel method optimizing the normalization of cardiac parameters in small animal models: the importance of dimensional indexingQuint A J Hagdorn, Guido P L Bossers, Anne-Marie C Koop, et al.Pageof 1